MedPath

Adverse Effects of ALA-PDT for the Treatment of Moderate to Severe Acne Vulgaris: a Prospective Study

Not Applicable
Completed
Conditions
Acne Vulgaris
Interventions
Other: Aminolevulinic acid, photodynamic therapy
Registration Number
NCT04709289
Lead Sponsor
Shanghai Dermatology Hospital
Brief Summary

To understand, prevent and treat the adverse reactions more comprehensively, we sought to systemically document the adverse effects of ALA-PDT for moderate to severe acne vulgaris.

Detailed Description

To understand, prevent and treat the adverse reactions more comprehensively, we sought to systemically document the adverse effects of ALA-PDT for moderate to severe acne vulgaris.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
40
Inclusion Criteria
  • (1) Patients diagnosed with moderate to severe acne and graded grade III-IV according to Investigator's Global Assessment (IGA) ;
  • (2) Patients unsuitable for drug treatment owing to various reasons and who voluntarily participated and signed informed consent following information about other alternatives;
  • (3) Patients who read the instructions and were willing to follow the program requirements.
Exclusion Criteria
  • (1) Patients who had a history of photosensitive diseases;
  • (2) Patients who had Modified-PDT;
  • (3) Patients who had oral isotretinoin in the past 3 months, used oral contraceptives or antibiotics and underwent local or facial surgery in the past 4 weeks;
  • (4) Female patients who were pregnant or lactating.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Conventional Photodynamic Therapy(C-PDT) groupAminolevulinic acid, photodynamic therapyThe conventional photodynamic therapy(C-PDT) group underwent narrow-band light-emitting diode (LED) irradiation (630 nm; 140 J/cm2) after applying 5% 5-aminolevulinic acid cream for 3h.A repeat treatment was administered once every two weeks for 3 times.
Primary Outcome Measures
NameTimeMethod
The clearance rate of lesions1 week after treatment

The change rate in lesion clearance of acne vulgaris at 7 days after treatment will be measured as the primary outcome

Secondary Outcome Measures
NameTimeMethod
Assessment of adverse effectsup to 7 days after treatment.

the incidence, severity, occurrence and duration time of erythema, pain, burning skin, itching, pustule, exudation, edema, blister, dry skin, crust and hyperpigmentation of last treatment, as well as lesion photos were detailed asked and recorded during the clinical encounter, up to 7 days after treatment.

Trial Locations

Locations (1)

Lei Shi

🇨🇳

Shanghai, Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath